hotspot -WSS

hotspot

author：focus 2025-10-04 11:35:49 - browse：7471

Christine Kao/STAT

The Food and Drug Administration’s approval on Friday of two gene therapies for sickle cell disease sets up what could be an intense competition between Bluebird Bio, maker of Lyfgenia, and the partnership of Vertex Pharmaceuticals and CRISPR Therapeutics, whose drug is Casgevy.

For the first time, physicians and patients will have a choice of potentially curative treatments for an inherited disease that affects nearly 100,000 Americans.

The Vertex/CRISPR team would seem to have the edge. As the first CRISPR-based therapy, Casgevy has the advantage of being powered by the latest and buzziest biological technology, though some physicians and patients may be more comfortable with the lentiviral vector technology behind Lyfgenia, which dates back to the 1990s — even with a “black box” warning of a risk of blood cancer added to its label.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen
Next article： How doctors and nurses shape Google's AI

WSS

In medicine, common shorthands can shortchange care

There’s no way to know how good AI health technologies are

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

Illinois to ban advertising for guns allegedly marketed to kids and militants

Medicare to cover more brain scans related to Alzheimer’s drugs

Massive project maps cells in human brain in unprecedented detail

knowledge

hotspot

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

Democratic lawmaker calls for 'well

Supreme Court strikes down use of affirmative action

Wellcome Trust names Røttingen as its new CEO

Medicare details structure of new drug price negotiation program

Massive project maps cells in human brain in unprecedented detail

Duchenne breakthrough therapy leaves behind pioneering families

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

There’s no way to know how good AI health technologies are

hotspot

How clinical AI models' predictive power can degrade over time

Massive project maps cells in human brain in unprecedented detail

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

Wellcome Trust names Røttingen as its new CEO

Cancer cells are shown to suck energy source from immune cells

'The Exorcist' director William Friedkin dead at 87

Wikipedia

entertainment

hotspot

entertainment